Tag Archives: @BUMedicine

COVID Effects on Nerves May Lead to Better Pain Relief Medications

Posted on by

PainRelief.com Interview with:
Venetia Zachariou PhD
Edward Avedisian Professor
Chair of Pharmacology, Physiology & Biophysics
Boston University Chobanian & Avedisian School of Medicine

PainRelief.com: What is the background for this study?

Response: COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death. For those with milder infections, COVID-19 can produce respiratory infection symptoms (cough, congestion, fever)  as well as loss of the sense of smell.

A substantial number of actively infected patients suffering from both mild and severe infections experience sensory-related symptoms, such as headache, visceral pain, Guillain-Barre syndrome (GBS), nerve pain and inflammation. In most patients these symptoms subside after the infection ends, but, for other patients, they can persist. 

Continue reading →

Elevated Mortality Risk for Women with Back Pain

Posted on by

PainRelief.com Interview with:
Eric Roseen, DC, MSc
Director of the Program for Integrative Medicine and Health Disparities
Boston Medical Center
Assistant Professor of Family Medicine
Boston University School of Medicine

PainRelief.com:  What is the background for this study?

Response: More than 80 percent of Americans will experience back pain at some point in their lives. Back pain is the leading cause of disability worldwide, and disability and inactivity are generally associated with greater mortality. Women and older adults, and those that experience more severe or persistent back pain, have an elevated risk of back-related disability. We were interested in whether back pain, in general or in these potentially at-risk subgroups, is associated with mortality. Thus, we conducted the first systematic literature review and meta-analysis of the association of back pain and all-cause mortality.

Continue reading →